Skip to main content
. Author manuscript; available in PMC: 2024 Dec 28.
Published in final edited form as: Addiction. 2023 Jul 19;118(11):2203–2214. doi: 10.1111/add.16289

TABLE 2.

Comparison of unadjusted average costs 0–30 days after the index date between the overdose and non-overdose cohorts (2020 US dollars).

Types of costs Opioid OD cohort (n = 1413) Non-opioid OD cohort (n = 65 100) P-value
Total costs ($), mean (SD) 21 686 (24 806) 3341 (9780) < 0.001
Inpatient cost categories ($), mean (SD)
 Total inpatient costs 15 929 (21 910) 1542 (8713) < 0.001
 Medical/surgical   8244 (17 846)  435 (6660) < 0.001
 Psychiatry/mental health   3465 (8606)  359 (2945) < 0.001
 Substance use treatment    838 (3604)  125 (1404) < 0.001
 Mental health residential rehabilitation treatment program    731 (3399)  378 (2596) < 0.001
 Other   1393 (8133)  155 (2619) < 0.001
Outpatient cost categories ($), mean (SD)
 Total outpatient costs   5542 (11 411) 1746 (3650) < 0.001
 Medical/surgical   1370 (1702)  457 (1254) < 0.001
 Psychiatry/mental health    572 (970)  286 (720) < 0.001
 Substance use treatment    346 (912)  194 (621) < 0.001
 Pharmacy    345 (1074)  305 (1331) < 0.001
 Mental health residential rehabilitation treatment program     40 (238)    9 (98) < 0.001
 Other   1525 (10 005)  330 (1187) < 0.001

Note: Of 1413 patients in our opioid overdose (OD) cohort, 148 (10.5%) died within the year after overdose. Of 65 100 patients in our non-OD cohort, 1999 (3.1%) died within the year after the index date. If a patient died during one of the post-index date periods, we assigned subsequent period costs to missing. Mann–Whitney U-tests were performed for non-parametric data.

Abbreviation: SD = standard deviation.